Daclatasvir+Sofosbuvir Tablet Suppliers & Bulk Manufacturers
Available Forms: Tablets
Available Strengths: 60+400mg
Reference Brands: Hepcinat Plus
Category:
Hepatitis
This is a combination medication containing Daclatasvir 60mg and Sofosbuvir 400mg. It is used to treat chronic hepatitis C infection in adults. Hepatitis C infection is a liver disease caused by the hepatitis C virus (HCV).
DACLATASVIR+SOFOSBUVIR TABLET is available in Tablets
and strengths such as 60+400mg.
Sourced from GMP-certified and ISO-compliant manufacturers, this API meets
global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical
formulation and commercial manufacturing, DACLATASVIR+SOFOSBUVIR TABLET is supplied in
bulk quantities with complete regulatory support including DMF, COA, and MSDS.
|
Technical Specifications & Supply Details
|
| Lead Time |
7 to 60 days (depending on batch size & schedule) |
| MOQ |
As per manufacturer’s batch size |
| COA |
Available with every batch |
| Regulatory Dossier / DMF |
Available upon request |
| Export Documentation |
FSC, COA, Manufacturing License, Product Permission |
| Standards |
IP, BP, USP |
| Certifications |
WHO-GMP, EU-GMP, USFDA (as applicable) |
DACLATASVIR+SOFOSBUVIR TABLET can be exported to over 30 countries across Asia, Africa, Europe,
and Latin America. Flexible packaging, competitive pricing, and a verified supplier
network make Pharmatradz a trusted sourcing partner for pharmaceutical companies
and contract manufacturers worldwide.
Product Description:
Talk to your doctor if you have liver problems other than hepatitis C infection, had a liver transplant, diabetes, heart disorders, severe kidney problems, or you are on dialysis before taking tablet.
Disclaimer: By continuing to browse, you agree to the terms of use of this website and the Trade Marks displayed, in compliance with the provisions of the Trademark Act, 1999, Section 30 and 30(1) under 'Fair use.'
The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Back to Listing